Engineers Gate Manager LP purchased a new stake in Cutera, Inc. (NASDAQ:CUTR) during the third quarter, according to its most recent 13F filing with the SEC. The firm purchased 11,186 shares of the medical device company’s stock, valued at approximately $364,000. Engineers Gate Manager LP owned approximately 0.08% of Cutera as of its most recent filing with the SEC.

Other large investors have also recently added to or reduced their stakes in the company. Gamco Investors INC. ET AL raised its position in Cutera by 3.4% during the 2nd quarter. Gamco Investors INC. ET AL now owns 591,800 shares of the medical device company’s stock worth $23,850,000 after buying an additional 19,337 shares during the last quarter. Partner Fund Management L.P. increased its holdings in shares of Cutera by 21.6% during the 2nd quarter. Partner Fund Management L.P. now owns 487,347 shares of the medical device company’s stock valued at $19,640,000 after purchasing an additional 86,621 shares in the last quarter. Gabelli Funds LLC increased its holdings in shares of Cutera by 9.2% during the 2nd quarter. Gabelli Funds LLC now owns 408,500 shares of the medical device company’s stock valued at $16,463,000 after purchasing an additional 34,500 shares in the last quarter. Peregrine Capital Management LLC increased its holdings in shares of Cutera by 0.7% during the 3rd quarter. Peregrine Capital Management LLC now owns 368,758 shares of the medical device company’s stock valued at $12,003,000 after purchasing an additional 2,666 shares in the last quarter. Finally, Teton Advisors Inc. increased its holdings in shares of Cutera by 14.2% during the 2nd quarter. Teton Advisors Inc. now owns 352,796 shares of the medical device company’s stock valued at $14,218,000 after purchasing an additional 43,796 shares in the last quarter.

CUTR traded down $0.69 on Friday, hitting $18.13. 102,739 shares of the company’s stock were exchanged, compared to its average volume of 157,219. Cutera, Inc. has a fifty-two week low of $17.94 and a fifty-two week high of $56.05. The stock has a market cap of $261.67 million, a PE ratio of 23.55 and a beta of 0.87.

Cutera (NASDAQ:CUTR) last announced its earnings results on Tuesday, November 6th. The medical device company reported $0.11 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.03 by $0.08. Cutera had a net margin of 11.16% and a negative return on equity of 0.50%. The company had revenue of $40.60 million for the quarter, compared to analysts’ expectations of $40.03 million. During the same quarter in the previous year, the company posted $0.42 EPS. The firm’s quarterly revenue was up 6.4% on a year-over-year basis. On average, sell-side analysts predict that Cutera, Inc. will post -0.29 EPS for the current year.

CUTR has been the subject of several recent research reports. BidaskClub lowered shares of Cutera from a “buy” rating to a “hold” rating in a report on Thursday, September 20th. Stephens dropped their price target on shares of Cutera from $40.00 to $24.94 and set a “sell” rating on the stock in a research note on Friday, October 5th. Stifel Nicolaus dropped their price target on shares of Cutera from $45.00 to $29.00 and set a “hold” rating on the stock in a research note on Friday, October 5th. Sidoti set a $50.00 price target on shares of Cutera and gave the company a “buy” rating in a research note on Friday, October 5th. Finally, ValuEngine cut shares of Cutera from a “buy” rating to a “hold” rating in a research note on Wednesday, August 29th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and three have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus target price of $39.24.

TRADEMARK VIOLATION WARNING: This report was originally posted by Marea Informative and is the property of of Marea Informative. If you are accessing this report on another publication, it was stolen and republished in violation of US & international copyright laws. The legal version of this report can be read at https://www.mareainformativa.com/news/2018/12/08/engineers-gate-manager-lp-buys-new-stake-in-cutera-inc-cutr-updated-updated-updated.html.

Cutera Profile

Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.

Featured Story: What Does Beta Mean In Stock Selection

Institutional Ownership by Quarter for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.